Outset Medical Inc (OM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Outset Medical Inc (OM) has a cash flow conversion efficiency ratio of -0.115x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-12.84 Million) by net assets ($111.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Outset Medical Inc (OM) defensive interval to measure how many days the company can operate on defensive assets alone.
Outset Medical Inc - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how Outset Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Outset Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Outset Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vow ASA
OL:VOW
|
0.300x |
|
JHM Consolidation Bhd
KLSE:0127
|
-0.009x |
|
Tsann Kuen Enterprise Co Ltd
TW:2430
|
0.135x |
|
Panache Digilife Limited
NSE:PANACHE
|
0.050x |
|
EML Payments Ltd
F:A8Y1
|
-0.016x |
|
Hindustan Media Ventures Limited
NSE:HMVL
|
0.012x |
|
Unitronics
TA:UNIT
|
0.153x |
|
Africa Energy Corp
V:AFE
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Outset Medical Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Outset Medical Inc from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see OM stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $126.95 Million | $-46.33 Million | -0.365x | +91.59% |
| 2024-12-31 | $26.82 Million | $-116.30 Million | -4.337x | -305.64% |
| 2023-12-31 | $122.89 Million | $-131.37 Million | -1.069x | -80.46% |
| 2022-12-31 | $245.99 Million | $-145.73 Million | -0.592x | -70.13% |
| 2021-12-31 | $374.08 Million | $-130.26 Million | -0.348x | -15.57% |
| 2020-12-31 | $328.61 Million | $-99.02 Million | -0.301x | -259.54% |
| 2019-12-31 | $-372.19 Million | $-70.29 Million | 0.189x | +17.10% |
| 2018-12-31 | $-287.95 Million | $-46.44 Million | 0.161x | -- |
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more